257 related articles for article (PubMed ID: 27090175)
1. Effect of Fidaxomicin versus Vancomycin on Susceptibility to Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
Antimicrob Agents Chemother; 2016 Jul; 60(7):3988-93. PubMed ID: 27090175
[TBL] [Abstract][Full Text] [Related]
2. Effect of Surotomycin, a Novel Cyclic Lipopeptide Antibiotic, on Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3333-9. PubMed ID: 26976870
[TBL] [Abstract][Full Text] [Related]
3. Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
Tomas ME; Mana TSC; Wilson BM; Nerandzic MM; Joussef-Piña S; Quiñones-Mateu ME; Donskey CJ
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530853
[TBL] [Abstract][Full Text] [Related]
4. Cadazolid Does Not Promote Intestinal Colonization of Vancomycin-Resistant Enterococci in Mice.
Seiler P; Enderlin-Paput M; Pfaff P; Weiss M; Ritz D; Clozel M; Locher HH
Antimicrob Agents Chemother; 2016 Jan; 60(1):628-31. PubMed ID: 26503650
[TBL] [Abstract][Full Text] [Related]
5. Impact of Oral Fidaxomicin Administration on the Intestinal Microbiota and Susceptibility to Clostridium difficile Colonization in Mice.
Ajami NJ; Cope JL; Wong MC; Petrosino JF; Chesnel L
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463537
[No Abstract] [Full Text] [Related]
6. Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.
Nerandzic MM; Mullane K; Miller MA; Babakhani F; Donskey CJ
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S121-6. PubMed ID: 22752860
[TBL] [Abstract][Full Text] [Related]
7. Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.
Louie TJ; Cannon K; Byrne B; Emery J; Ward L; Eyben M; Krulicki W
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S132-42. PubMed ID: 22752862
[TBL] [Abstract][Full Text] [Related]
8. Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae in mice.
Pultz NJ; Stiefel U; Donskey CJ
Antimicrob Agents Chemother; 2005 Aug; 49(8):3513-6. PubMed ID: 16048971
[TBL] [Abstract][Full Text] [Related]
9. Distinct but Spatially Overlapping Intestinal Niches for Vancomycin-Resistant Enterococcus faecium and Carbapenem-Resistant Klebsiella pneumoniae.
Caballero S; Carter R; Ke X; Sušac B; Leiner IM; Kim GJ; Miller L; Ling L; Manova K; Pamer EG
PLoS Pathog; 2015 Sep; 11(9):e1005132. PubMed ID: 26334306
[TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.
Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
Infect Control Hosp Epidemiol; 2004 May; 25(5):373-9. PubMed ID: 15188841
[TBL] [Abstract][Full Text] [Related]
11. Fidaxomicin: a novel macrocyclic antibiotic for the treatment of Clostridium difficile infection.
Crawford T; Huesgen E; Danziger L
Am J Health Syst Pharm; 2012 Jun; 69(11):933-43. PubMed ID: 22610025
[TBL] [Abstract][Full Text] [Related]
12. A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.
Tannock GW; Munro K; Taylor C; Lawley B; Young W; Byrne B; Emery J; Louie T
Microbiology (Reading); 2010 Nov; 156(Pt 11):3354-3359. PubMed ID: 20724385
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant enterococci in mice.
Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
Antimicrob Agents Chemother; 2004 Jun; 48(6):2144-8. PubMed ID: 15155213
[TBL] [Abstract][Full Text] [Related]
14. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium.
Caballero S; Kim S; Carter RA; Leiner IM; Sušac B; Miller L; Kim GJ; Ling L; Pamer EG
Cell Host Microbe; 2017 May; 21(5):592-602.e4. PubMed ID: 28494240
[TBL] [Abstract][Full Text] [Related]
15. Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice.
Perez F; Pultz MJ; Endimiani A; Bonomo RA; Donskey CJ
Antimicrob Agents Chemother; 2011 Jun; 55(6):2585-9. PubMed ID: 21422202
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.
Warren CA; van Opstal EJ; Riggins MS; Li Y; Moore JH; Kolling GL; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2013 Feb; 57(2):689-96. PubMed ID: 23147742
[TBL] [Abstract][Full Text] [Related]
17. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
Özsoy S; İlki A
Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
[TBL] [Abstract][Full Text] [Related]
18. Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.
Lewis BB; Buffie CG; Carter RA; Leiner I; Toussaint NC; Miller LC; Gobourne A; Ling L; Pamer EG
J Infect Dis; 2015 Nov; 212(10):1656-65. PubMed ID: 25920320
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.
Stiefel U; Nerandzic MM; Pultz MJ; Donskey CJ
Antimicrob Agents Chemother; 2014 Aug; 58(8):4535-42. PubMed ID: 24867962
[TBL] [Abstract][Full Text] [Related]
20. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
[No Abstract] [Full Text] [Related]
[Next] [New Search]